Browse By: Country ι Category ι Latest Reports ι Tag
Home  »  In Vitro Diagnostics

In Vitro Diagnostics Market Research Reports

In Vitro diagnostics (IVD) market plays an integral role in detecting or diagnosing infections or diseases under stringent environments such as a laboratory. IVD industry holds a major role in the disease and healthcare management sector. Due to advances in bioinformatics, genomics, microelectronics, and miniaturization, the past few years have changed dramatically for diagnostic laboratory technology. 

t-align: justify;>In vitro diagnostics market is highly reliable when it comes to providing valuable information regarding the physiological and/or pathological state of a patient suffering from a disease. This industry has spread its wings into the clinical and traditional medical engineering segments to blend with industry-specific components derived from computer sciences opening up new niche markets for diagnostic testing. IVD is very essential in the clinical domain to take well-informed medical decisions.  


For the past 15 years, this market has witnessed number of assays growing in an upswing. IVD has contributed to growth in many medical areas, especially in nucleic acid and immunoassays tests. 


A number of patients have succumbed to infectious diseases such as gastrointestinal, sexually transmitted diseases, or respiratory problems. The growing global prevalence of chronic and infectious diseases such as, Chagas, cholera, human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), tuberculosis, measles, Herpes Simplex Virus (HSV), dengue, and malaria will effectively cause an impact on the overall market during the next years. Hence, the global In Vitro Diagnostics Market is growing due to ongoing developments in microbiology, analytical laboratory automation and swift progress in different fields of diagnosis such as molecular diagnosis, point-of-care testing, and immunoassays.  


The global In Vitro market has witnessed dynamic market conditions in terms of rising incidences of chronic diseases, rising per capita income, increasing awareness of health and fitness, demand of efficient and effective health care equipment, as well as major technological advancements. Patients’ self-testing their medical conditions is the most important trend witnessed in the IVD market. A paradigm shift from laboratory testing to point of care testing is one of the major factors responsible for the growth of this industry.


Through Marketresearchreports.biz, you will learn the overall industry nature including the market trends, analysis, and forecasts of the In Vitro Diagnostics market. We provide you with quality-based market research reports that that will decisively give you the edge you need and help you take decisions accordingly.

More

Global Foley Catheters Market 2015-2019
About Foley Catheters A Foley catheter, also called the indwelling catheter, is inserted into the bladder to drain urine. It comprises a balloon that holds the catheter in the bladder at one end. The balloon is filled with sterile water to prevent the catheter from being removed from the bladder. Urine is drained through the catheter tube into a collection bag. Foley catheters are used for long periods such as for weeks or a month. These catheters are used after urological surgeries to help patients urinate with ease, in conditions such as nerve-related bladder dysfunction prostate hypertrophy, prostate cancer, and narrowing of the urethra.  TechNavio's analysts forecast the Global Foley Catheters market to grow at a CAGR of 2.65 percent over the period 2015-2019. C
Published Date: Mar 2015
Published By: Technavio

Price: $3000
Global Hip Implant Market 2015-2019
About Hip Implant Hip replacement is an orthopedic surgical procedure in which the damaged hip joint is replaced with an artificial joint. An artificial joint usually made from metal, ceramic, or polymeric components. The surgery is performed either by traditional technique or by minimally invasive technique. The hip replacement surgery is generally performed in patients to relieve them from arthritis pain or hip fracture. Hip replacement surgery can be total hip replacement (replacing the entire hip), partial replacement (replacing half of the joint with an artificial surface, leaving the other part in its natural state), and hip surfacing (replacing damaged bone and cartilage within the socket is removed and replaced with a metal shell). TechNavio's analysts forecast the Global
Published Date: Mar 2015
Published By: Technavio

Price: $2500
Global Intermittent Catheters Market 2015-2019
About Intermittent Catheters Intermittent catheters are used for emptying the urinary bladder in patients who lose control over their bladder. These catheters are used for short term. Urine incontinence can be caused due to neurogenic bladder disorders such as spinal cord injury, spina bifida or multiple sclerosis, and non-neurogenic bladder disorders. The catheter is inserted into the urethra and guided to the bladder causing the urine to flow through the catheter tube and drain into the collection bag. Once the bladder is emptied, the catheter can be removed. Self- catheterization is also possible with these catheters; even children of seven or eight years can be trained to handle catheterization on their own. A parent or caregiver can help in case a patient is physically ill.
Published Date: Mar 2015
Published By: Technavio

Price: $3000
Global Joint Reconstruction Market 2015-2019
About Joint Reconstruction Joint reconstruction is a procedure in which a damaged or dysfunctional joint or tissue is replaced by an artificial prosthesis. Artificial prostheses are made up of different types of materials, including metals, plastics, and ceramics. The common types of joint replacement procedures include hip and knee replacement procedures, and procedures on extremities such as ankles, wrists, shoulders, and elbows. TechNavio's analysts forecast the Global Joint Reconstruction market to grow at a CAGR of 5.55 percent over the period 2014-2019. Covered in this Report The Global Joint Reconstruction market can be segmented into Knee Implants, Hip Implants, and Trauma & Extremities. TechNavio's report, Global Joint Reconstruction Market 2015-2019, has be
Published Date: Mar 2015
Published By: Technavio

Price: $2500
Companion Diagnostics Deals and Alliances of 2014
The Companion Diagnostics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of leading deals by deal values, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Diagnostics Deals and Alliances of 2014
The Diagnostics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, miles
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Roche Diagnostics International Ltd - Product Pipeline Analysis, 2015 Update
Roche Diagnostics International Ltd. (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devicesanalyzers, blood glucose meterslaboratory information, workflow and data management softwareand instruments and reagents for life science research. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. It has operations in the Americas, Asia Pacific, Africa, the Middle East and Europe. Roche Diagnostics manages all the central functions of the Diagnostics business of F. Hoffmann-La Roche Ltd. and is headquartered in Rotkreuz, Switzerland. This report
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Global POC Diagnostics Market 2015-2019
About POC Diagnostics POC diagnostics are IVD devices and tools used for diagnosing diseases in patients outside a clinical laboratory setting. The use of these devices helps in the rapid diagnosis of the medical conditions and aids in providing appropriate treatments and medication to patients. They are cost-effective, user-friendly, and standardized to minimize errors during diagnosis. They are being used extensively for diagnostic purposes owing to the high prevalence of lifestyle diseases such as diabetes and obesity, cardiac disorders, and infectious diseases. They have a wide range of applications in clinical diagnosis such as the testing of blood glucose and coagulation, infectious diseases, cardiac markers, pregnancy and fertility, blood gas/electrolytes, tumor markers, urin
Published Date: Feb 2015
Published By: Technavio

Price: $3000
Siemens Healthcare - Product Pipeline Analysis, 2015 Update
Siemens Healthcare (formerly Siemens Medical Solutions) is a global medical device company. It undertakes the design, development, manufacture and distribution of medical devices and technologies for diagnostic markets. It offers imaging equipment, healthcare information systems, management consulting, and support services. It has a comprehensive portfolio of medical solutions, ranging from medical imaging, in vitro diagnostics, and interventional systems to clinical IT. It conducts operations in North America, Africa, Europe, Asia and Australia. Siemens Healthcare is a business unit of Siemens AG and is headquartered in Erlangen, Germany.The company focuses on innovation to develop new products and expand its markets in BRIC countries (Brazil, Russia, India and China). With an intent to
Published Date: Feb 2015
Published By: GlobalData

Price: $750
Global In-Vitro Diagnostics (IVD) Market Report: 2014 Edition
An in-vitro diagnostic test is performed outside of a human body in an artificial environment (e.g. laboratory). IVD is considered as an essential part of today’s healthcare. The IVD products are broadly divided into three categories: reagents, analytical instruments and accessory products. IVD is widely used for diagnosis, monitoring of prescribed treatments and assessment of medical intervention, apart from others thereby contributing to availability of medical information regarding a patient. Furthermore, IVD allows earlier and more targeted treatment which in turn leads to reduced hospital stays and convalescences resulting in a healthier population and economic growth in the long run. A constant growth has been observed in the global IVD industry since 2009. In IVD by technol
Published Date: Jan 2015
Published By: Koncept Analytics

Price: $800
Blood Coagulation Analyzer - Product Analysis
This 125 page report ""Blood Coagulation Analyzer – Product Analysis"" contains 4 figures and 40 Tables provides a comprehensive assessment of the blood coagulation products of the companies. It examines the latest available and emerging coagulation tests and products being utilized by the coagulation testing field and describes the current product lines of almost all of the companies known to be marketing and manufacturing instruments for blood coagulation testing. Each company is discussed in depth with a section on its product line, sales figures and a competitive/comparative tests and product analysis of the company.  All the Blood Coagulation Analyzers in the report have been studied from 5 viewpoints. 1. Analyzer Benefits and Feature 2. Specifications 3. Net
Published Date: Jan 2015
Published By: Renub Research

Price: $900
Global Cervical Cancer Diagnostic Tests Industry 2014 Market Research Report
2014 Global Cervical Cancer Diagnostic Tests Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Cervical Cancer Diagnostic Tests industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).The report firstly introduced the Cervical Cancer Diagnostic Tests basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introd
Published Date: Jan 2015
Published By: 9Dimen Research

Price: $2850
Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 270 tables & figures over 254 pages. The personalized medicine (global) market is presented as follows: By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD) By Geography (US, UK, EU) By Segment (Targeted therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services) By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics) A wealth of financial data & business strategy information is provided including: Company financials, sales & rev
Published Date: Jan 2015
Published By: Kelly Scientific Publications

Price: $3400
China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis
China is gradually becoming a competitive force and evolving into the world’s fastest growing market for In Vitro Diagnostics (IVD) products. By 2018 Chinese IVD market with Billion US$ is expected to be twice more than from its current market size in 2013. Immunoassay has the highest market share compared to all other segments of In Vitro Diagnostics. Clinical Chemistry is in the 2nd position, but its market share is declining year on year, however its market is growing year on year. Molecular Diagnostics holds the 3rd position and its market share is also rising year on year. Roche holds the highest market share in China In Vitro Diagnostics market.  This is 3rd edition report on In Vitro Diagnostics sector by Renub Research. Report titled “China In Vitro Diagnostics
Published Date: Dec 2014
Published By: Renub Research

Price: $1400
Non-Invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi and VisibiliT) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2014 - 2020
Non-invasive prenatal testing (NIPT) is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and Turner syndrome (monosomy X), and also for fetal sex determination. Until recently, amniocentesis, chorionic villus sampling (CVS), maternal serum screening and nuchal translucency (NT) scan were the primary diagnostic and screening methods for chromosomal abnormalities. Advent of non-invasive prenatal test is poised to eliminate disadvantages associated with these methods, such as low rate of accuracy with maternal serum screening and NT scan, and risk of miscarriage with invasive amniocentesis and CVS procedures. This report on non-invasive prenatal testin
Published Date: Nov 2014
Published By: Transparency Market Research

Price: $4795
Molecular Diagnostics Partnering Terms and Agreements
The Molecular Diagnostics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.     This report provides details of the latest molecular diagnostics agreements announced in the healthcare sectors.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - co
Published Date: Oct 2014
Published By: Current Partnering

Price: $1995
China Diagnostic Reagent Industry Report, 2013-2016
With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic reagent industry has been developing quickly, especially in vitro diagnostic reagents occupy over 90%. In 2013, Chinese in vitro diagnostics market size reached RMB22.98 billion, of which RMB16.61 billion came from in vitro diagnostic reagents.    Chinese in vitro diagnostic reagent market consists of biochemical diagnostic reagents, immunodiagnostic reagents and molecular diagnostic reagents. Among them, the immune reagents and biochemical reagents account for a relatively higher combined proportion, such as around 65% in 2013. Currently, about 40%-50% share of the Chinese in vit
Published Date: Jul 2014
Published By: Research In China

Price: $2400
Global Molecular Diagnostics Market Report: 2014 Edition
Over the years, medical science has made unprecedented progress in almost every sphere of human anatomy. In the pursuit, pathological sciences, in particular, have brought forth advancements that rendered the possibility of deploying certain tests that are performed on patient samples, including blood and tissues, in order to detect the presence of concerning physiological/pathological state, or concerning congenital abnormality. Essentially, In-vitro Diagnostics (IVD) have earned the title of ‘silent champion’ of the healthcare industry since this segment influences more than half of the decision-making in the overall healthcare industry.   Under this umbrella, the fastest growing segment, i.e. molecular diagnostics, involves performing analysis at the molecular level,
Published Date: Jul 2014
Published By: Koncept Analytics

Price: $800
DiaSorin S.p.A (DIA) - Product Pipeline Analysis, 2014 Update
DiaSorinS.p.A. (DiaSorin) is a medical device company. It undertakes the development and manufacture of reagents pertaining to in-vitro diagnostics and systems that enable automatic diagnostic investigation. The company offers products grouped under two segments, namely, immunodiagnostics, and molecular diagnostics. Its key products offerings include radio immuno assays (RIA), enzyme linked immunosorbent assays (ELISA) and chemiluminescent immuno assays (CLIA) under immunediagnosticssegmentand extraction, amplification, and diagnostic products under molecular diagnostics segment. The company also develops and distributes immune reagent kits for clinical diagnostics and equipment that are to be used in combination with reagents, to facilitate automatic diagnostic investigation. The comp
Published Date: Jun 2014
Published By: GlobalData

Price: $750
Alere Inc. (ALR) - Product Pipeline Analysis, 2014 Update
Alere Inc. (Alere), (formerly Inverness Medical Innovations, Inc.) is one of the leading providers of point-of-care diagnostics solutions and services. Its solutions and services enable patients to take charge of their own health at home and allow healthcare providers and payors to enhance care, prevent disease advancement and reduce healthcare costs. The company provides near-patient monitoring tools and value-added healthcare services. Its products and services focus on cardiology, women’s health, infectious diseases, diabetes, oncology, and toxicology. Its portfolio portfolio also includes a broad array of health information solutions which increase access to critical health data, provide clinical decision support, and facilitate augmented performance reporting and analysis. I
Published Date: Jun 2014
Published By: GlobalData

Price: $750
Quest Diagnostics Incorporated (DGX) - Product Pipeline Analysis, 2014 Update
Quest Diagnostics Incorporated (Quest Diagnostics) is a medical diagnostics company. It offers diagnostic testing services to patients and physicians through a chain of laboratories and company-owned patient service centers. The company offers comprehensive services such as clinical testing, with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology, and diagnostic products. Quest Diagnostics, along with its subsidiaries and branches, operates in India, Ireland, Mexico, Sweden, the UK, the US, Singapore, China, South America and Australia. Quest Diagnostics is headquartered in Madison, New Jersey, the US.The company intends to grow through acquisitions. To this end, in August 2014, Quest acquir
Published Date: Jun 2014
Published By: GlobalData

Price: $750
Abbott Diagnostics - Product Pipeline Analysis, 2014 Update
Abbott Diagnostics is a provider of in vitro diagnostic products. It provides a wide range of innovative diagnostic instruments, tests and systems for hospitals, blood banks, commercial laboratories, clinics and alternate-care testing sites. The company\'s products range from automated immunodiagnostic systems and blood analyzers to advanced molecular diagnostics and point-of-care devices. It offers core laboratory diagnostic products, including an array of instruments and tests for the global diagnostic market. Besides, it offers immunoassay and clinical chemistry products such as systems and assays for the measurement of a variety of antibodies, antigens and analytes in the blood and for the diagnosis and monitoring of diseases and therapies. It provides blood-screening instrumentati
Published Date: Jun 2014
Published By: GlobalData

Price: $750
bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2014 Update
bioMerieux S.A. (bioMerieux) undertakes the design, development and manufacture of diagnostic systems and reagents for physicians and biologists. It operates through two business divisions, namely, Clinical Applications and Industrial Applications. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used in diagnosing infectious diseases and provide high medical value results in cancer screening and monitoring and cardiovascular emergencies. Its products also detect microorganisms in food, pharmaceutical and cosmetic products. The company conducts its operations through subsidiaries and a broad network of distributors. bioMerieux is a part of the Institut Merieux group and is headquartered in Marcy lEtoile, France. The company
Published Date: Jun 2014
Published By: GlobalData

Price: $750
Cepheid (CPHD) - Product Pipeline Analysis, 2014 Update
Cepheid is a molecular diagnostic company. It develops, manufactures and commercializes fully-integrated systems for clinical and non-clinical market tests. The company\'s products for clinical markets include IVD medical devices, CE marked products, and research use only tests in the areas of healthcare associated infections, critical infectious disease, sexual health, womens health, virology, oncology and genetics. Cepheids two major systems include the SmartCycler and GeneXpert. The company also offers GeneXpert modules integrated into the biohazard detection systems using its bacillus anthracis test, and its SmartCycler system along with general use PCR reagents and reaction tubes to the non-clinical market. It operates along with its subsidiaries in France, Sweden, the US, Japan,
Published Date: Jun 2014
Published By: GlobalData

Price: $750
MDxHealth SA (MDXH) - Product Pipeline Analysis, 2014 Update
MdxHealth SA (MdxHealth), formerly OncoMethylome Sciences SA, is a molecular diagnostics company. It develops and commercializes advanced epigenetic assays and service testing for the early detection of cancer and personalized treatment decisions. It offers clinical molecular diagnostics solutions (clinicalMdx solution) and pharmaco molecular diagnostics (pharmacoMDx) solutions. The companys products include ConfirmMDx, which detects absence or presence of prostate cancerPredictMDx, which indicates patient response to therapy. Its product pipeline includes InformMDx for prostate cancerand ConfirmMDx and RecurMDx for bladder cancer. The company\'s tests are based on its proprietary MSP methylation technology that assists physicians in the diagnosis of cancer. It also provides indication
Published Date: Jun 2014
Published By: GlobalData

Price: $750
Blood Products Markets in China
China\'s demand for Blood Products has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China\'s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
Published Date: Jun 2014
Published By: Asia Market Information & Development Company

Price: $4000
Home Testing Products Markets in China
China\'s demand for Home Testing Products has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China\'s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
Published Date: May 2014
Published By: Asia Market Information & Development Company

Price: $4000
Hemoglobin A1c Testing Devices Market (End-use - Laboratory and Point-of-Care Testing Devices; Technologies - Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
This study covers the market analysis for various technologies and end-uses of hemoglobin A1c (HbA1c) testing devices. The stakeholders for this report include manufacturers of hemoglobin A1C testing analyzers and research organizations involved in developing new and innovative technologies for hemoglobin A1c testing. The market overview section of this report gives a detailed description about the market dynamics and trends including drivers, restraints and opportunities that influence the current and future scenario of this market. This section also covers market attractiveness analysis and Porter’s five forces analysis to give an understanding about the competitive scenario of global hemoglobin A1C testing devices market.  The global hemoglobin A1c testing devices mar
Published Date: May 2014
Published By: Transparency Market Research

Price: $4795
Global and China Over-the-Counter Diagnostic Products Industry 2014 Market Research Report
The report firstly introduced Over-the-Counter Diagnostic Products basic information included Over-the-Counter Diagnostic Products definition Over-the-Counter Diagnostic Products classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Military Infrared (EO/IR) Systemss industry policy and plan, Over-the-Counter Diagnostic Products product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Military Infrared (EO/IR) Systemss capacity production cost Over-the-Counter Diagnostic Products profit production value gross margin etc details information, at the same time, statistics t
Published Date: Apr 2014
Published By: QYResearch

Price: $2200
Global and China Flow Cytometers Industry 2014 Market Research Report
The report firstly introduced Flow Cytometers basic information included Flow Cytometers definition Flow Cytometers classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Military Infrared (EO/IR) Systemss industry policy and plan, Flow Cytometers product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Military Infrared (EO/IR) Systemss capacity production cost Flow Cytometers profit production value gross margin etc details information, at the same time, statistics these manufacturers Flow Cytometers products customers application capacity market position company contac
Published Date: Apr 2014
Published By: QYResearch

Price: $2200
mHealth Monitoring And Diagnostic Medical Devices Market (Focus On Medical Devices With In-Built Plug-Ins For Connectivity With Devices Like Smartphones And Tablets) Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
mHealth is an abbreviation for mobile health, a term used for the practice of medicine and public health supported by mobile devices. The term is most commonly used in reference to using mobile communication devices such as mobile phones, tablets, computers and PDAs for health services and information. This report studies the current scenario as well as the future market potential for mHealth monitoring and diagnostic devices (focus on medical devices with in-built plug-ins for connectivity with devices like smartphones and tablets) globally. The mHealth monitoring and diagnostic devices market has been segmented into seven major product types, namely, glucose monitors, blood pressure monitors, pulse oximeters, cardiac monitors, sleep apnea monitors, multi-parameter monitoring devices and
Published Date: Apr 2014
Published By: Transparency Market Research

Price: $4795
Disposable Gloves (Natural Rubber, Vinyl, Nitrile and Others) Market for Medical and Non-Medical (Food, Cleanroom, Industrial and Other) Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
The global market for disposable gloves is primarily driven by the growing healthcare industry and increasing awareness of hygiene among patients as well as healthcare providers. Disposable gloves have served the medical sector effectively in terms of safety, hygiene and cost-effectiveness. This study analyzes, estimates, and forecasts the global disposable gloves market from the demand perspective, based on volume (million pieces) and revenue (USD million) from 2013 to 2019. The report also analyzes several driving and restraining factors of the market along with their impact over the forecast period. The report provides a detailed view of the disposable gloves market by analyzing the key segments: product and applications. The report segments the market into key products such a
Published Date: Apr 2014
Published By: Transparency Market Research

Price: $4795
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide
Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA test is most adoptable test in developing countries as it is cheaper in comparison to Pap smear test and HPV DNA test. Cervical cancer test market is dominated by United States in 2013. Germany and United Kingdom are other top two leaders in this market place. In Asian region, China and India are top two countries having largest cervical cancer test population. Few countries have also shown a decline in cervical cancer test market. However VIA test market accounts for largest share in cervica
Published Date: Apr 2014
Published By: Renub Research

Price: $1490
Global and China Molecular Diagnostics equipment Industry 2014 Market Research Report
The report firstly introduced Molecular Diagnostics equipment basic information included Molecular Diagnostics equipment definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Molecular Diagnostics equipment industry policy and plan, Molecular Diagnostics equipment product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Molecular Diagnostics equipment capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Molecular Diagnostics equipment products customers application capacit
Published Date: Mar 2014
Published By: QYResearch

Price: $2200
Global and China Clinical Chemistry Analyzers Industry 2014 Market Research Report
The report firstly introduced Clinical Chemistry Analyzers basic information included Clinical Chemistry Analyzers definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Clinical Chemistry Analyzers industry policy and plan, Clinical Chemistry Analyzers product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Clinical Chemistry Analyzers capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Clinical Chemistry Analyzers products customers application capacity market position
Published Date: Mar 2014
Published By: QYResearch

Price: $2200
Multiplexed Diagnostics Market (Technologies: Very High, High, Medium, Low Density Multiplexed Assays & Next-Generation Sequencing; Applications: Infectious Disease Diagnosis, Oncology, Autoimmune Diseases, Cardiac, Allergies and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, quantitative PCR bead-based and microplate assays and next-generation sequencing. Further this market is also segmented on the basis of several application areas of multiplexed diagnostics, namely, infectious disease diagnosis, oncology, autoimmune diseases, cardiac conditions, allergies and others (Alzheimer’s disease, diabetes, kidney toxicity and HIV). The global multiplexed diagnostics m
Published Date: Mar 2014
Published By: Transparency Market Research

Price: $4795
Global and China Cardiac diagnosis instrument Industry 2014 Market Research Report
The report firstly introduced Cardiac diagnosis instrument basic information included Cardiac diagnosis instrument definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Cardiac diagnosis instrument industry policy and plan, Cardiac diagnosis instrument product specification, manufacturing process, cost structure etc. then statistics Global and China key manufacturers Cardiac diagnosis instrument capacity production cost price profit production value gross margin etc information, and Global and China Cardiac diagnosis instrument capacity production market share supply demand shortage import export consumption etc data statistics, and Cardiac
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Coronary Heart Disease Treatment Instrument Industry 2014 Market Research Report
The report firstly introduced Coronary Heart Disease Treatment Instrument basic information included Coronary Heart Disease Treatment Instrument definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Coronary Heart Disease Treatment Instrument industry policy and plan, Coronary Heart Disease Treatment Instrument product specification, manufacturing process, cost structure etc. then statistics Global and China key manufacturers Coronary Heart Disease Treatment Instrument capacity production cost price profit production value gross margin etc information, and Global and China Coronary Heart Disease Treatment Instrument capacity production mark
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China General Assay & Diagnostic Apparatuses Industry 2014 Market Research Report
The report firstly introduced General Assay & Diagnostic Apparatuses basic information included General Assay & Diagnostic Apparatuses definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, General Assay & Diagnostic Apparatuses industry policy and plan, General Assay & Diagnostic Apparatuses product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers General Assay & Diagnostic Apparatuses capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers General Assay &
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China B-type Ultrasonic Diagnostic Apparatus Industry 2014 Market Research Report
The report firstly introduced B-type Ultrasonic Diagnostic Apparatus basic information included B-type Ultrasonic Diagnostic Apparatus definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, B-type Ultrasonic Diagnostic Apparatus industry policy and plan, B-type Ultrasonic Diagnostic Apparatus product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers B-type Ultrasonic Diagnostic Apparatus capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers B-type Ultrasonic Diagnostic Appara
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Ultrasonic Diagnostic Apparatus Industry 2014 Market Research Report
The report firstly introduced Ultrasonic diagnostic apparatus basic information included Ultrasonic diagnostic apparatus definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Ultrasonic diagnostic apparatus industry policy and plan, Ultrasonic diagnostic apparatus product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Ultrasonic diagnostic apparatus capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Ultrasonic diagnostic apparatus products customers application capacit
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Blood Pressure Monitors Industry 2014 Market Research Report
The report firstly introduced Blood Pressure Monitors basic information included Blood Pressure Monitors definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Blood Pressure Monitors industry policy and plan, Blood Pressure Monitors product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Blood Pressure Monitors capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Blood Pressure Monitors products customers application capacity market position company contact information et
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Diagnostic Ultrasound System Industry 2014 Market Research Report
The report firstly introduced Diagnostic Ultrasound System basic information included Diagnostic Ultrasound System definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Diagnostic Ultrasound System industry policy and plan, Diagnostic Ultrasound System product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Diagnostic Ultrasound System capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Diagnostic Ultrasound System products customers application capacity market position
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Automated Hematology Analyzer Industry 2014 Market Research Report
The report firstly introduced Automated hematology analyzer basic information included Automated hematology analyzer definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Automated hematology analyzer industry policy and plan, Automated hematology analyzer product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Automated hematology analyzer capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Automated hematology analyzer products customers application capacity market pos
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Blood Circulation Machine Industry 2014 Market Research Report
The report firstly introduced Blood Circulation Machine basic information included Blood Circulation Machine definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Blood Circulation Machine industry policy and plan, Blood Circulation Machine product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Blood Circulation Machine capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Blood Circulation Machine products customers application capacity market position company contact in
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Neuropathology Industry 2013 Market Research Report
The report firstly introduced Neuropathology basic information included Neuropathology definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Neuropathology industry policy and plan, Neuropathology product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Neuropathology capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Neuropathology products customers application capacity market position company contact information etc company related information, then collect all these
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Investigation Report on China Enoxaparin Sodium Market, 2009 - 2018
Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. It can result in anoxia, the complete deprivation of oxygen and infarction, and even tissue death. Twelve million people worldwide are killed every year by cardiovascular and cerebrovascular diseases such as cerebral thrombosis, cerebral infarction, myocardial infarction, coronary heart disease and arteriosclerosis. It equals to nearly one-fourth of global death toll. Incidence of cardiovascular diseases keeps rising in China. The number of cardiovascular diseases patients in China now is estimated to be 290 million with 2 patients among 10 adults. It is estimated that about 3.5 million people die of cardiovascular diseases every year in China. This number has to
Published Date: Feb 2014
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1800
Research and Forecast of China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2014-2018
Research and Forecast of China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2014-2018 mainly conducts in-depth analysis on the external environment, market operation, import & export of China\'s IVD reagent industry, and also summaries the latest development of key Chinese domestic enterprises in 2013, and finally forecasts the future industrial development. The information can offer investors the decisive reference for their investment in the field. IVD reagent industry is an emerging industry in China, the start is late and the development is relatively backward compares with occidental countries. According to the data provided by IVD Special Committee, there are 300 to 400 IVD reagent manufacturing enterprises in China, of which, 200 enterprises own above designated scale.
Published Date: Feb 2014
Published By: Huidian Research

Price: $2150
Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular level. This class of diagnostics tests is considered as the most well established and lucrative market in the clinical applications segment. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost per sample analysis, labor costs, improvements in automation and introduction of advanced technologies have expanded the usage of molecular diagnostics tests. The growth of this market is expected to surge due to various factors such as rise in incidence of hospital acquired infections,
Published Date: Feb 2014
Published By: Transparency Market Research

Price: $4795
Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. 
Published Date: Feb 2014
Published By: Transparency Market Research

Price: $4795
MediPoint: Diagnostic Ultrasound Imaging - US Analysis and Market Forecasts
An early diagnosis of disease is the foundation for increasing survival rates. Diagnostic ultrasound imaging is the most widely used technique to achieve early detection and clinical assessment of adult and pediatric patients alike, making it a cornerstone of disease control. This report provides an analysis of the diagnostic ultrasound imaging market in the US, the 5EU (France, Germany, Italy, Spain, and UK), Brazil, and the some of the Asia-Pacific (APAC) regions (Japan, China, and India), and identifies the unmet needs in this ultrasound systems market. This report also discusses physician attitudes towards current diagnostic ultrasound techniques, and the future of diagnostic ultrasound imaging in the face of rapid technological advancements. As with other developed countries, t
Published Date: Jan 2014
Published By: GlobalData

Price: $4450
Global In Vitro Diagnostics (IVD) Market Report: 2013 Edition
The process of performing a diagnostic test outside of a living organism in an artificial environment, usually a laboratory, is called in-vitro diagnostic (IVD). IVD is considered as an essential part of today’s healthcare. The IVD products are broadly divided into three categories: reagents, analytical instruments and accessory products. IVD is widely used for diagnosis, monitoring of prescribed treatments and assessment of medical intervention, apart from others thereby contributing to availability of medical information regarding a patient. Further, IVD allows earlier and more targeted treatment which in turn leads to reduced hospital stays and convalescences resulting in a healthier population and economic growth in the long run. A consistent increase has been observed in the
Published Date: Jan 2014
Published By: Koncept Analytics

Price: $800
Diagnostic Substances (Global) - Industry Report
Plimsoll Publishing’s Diagnostic Substances (Global) Analysis provides a detailed overview of the Diagnostic Substances (Global) market and delivers a comprehensive individual analysis on the top 60 companies, including ROCHE DIAGNOSTICS GMBH, BERLIN-CHEMIE/MENARINI PHARMA GMBH and ABBOTT ARZNEIMITTEL GMBH.  This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Diagnostic  Substances (Global) analysis is ideal for anyone wanting to: See the market leaders Identify companies heading for failure Seek out the most attractive acquisition Analyse industry trends Benchmark their own financial performance Using Plimsoll’s exclusive methodology, a quick glance of this Diagnosti
Published Date: Jan 2014
Published By: Plimsoll Publishing Ltd.

Price: $1425
MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts
GlobalData has released its medical devices report, “MediPoint: Drug-Eluting Balloons EU Analysis and Market Forecasts”. The report provides in-depth insight into the use of DEB in the European Union (EU) for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chronic total occlusions, acute myocardial infarction and lesions in diabetics. The DEB market in the five major EU countries including France, Germany, Italy, Spain and the UK was assessed to identify and determine whether the current unmet needs are addressed, understand the challenges of DEB angioplasty and evaluate the current and future adoption of DEB for select coronary and per
Published Date: Sep 2013
Published By: GlobalData

Price: $4450
Global and China Diagnostic Reagent 2013 Industry Report
The report firstly introduceds diagnostic reagent basic information included definition classification market demand; market demand trends, international market analysis, China domestic market analysis, Diagnostic Reagent product specification etc. then statistics China key manufacturers Diagnostic Reagent market share percentage and market sales etc details information, at the same time, statistics the biochemical diagnoatics, immune dianostics, molecular diagnostics products market sales and market share etc information, then collect all these manufacturers data and listed China Diagnostic Reagent market share and market sales etc data statistics, and then introduced China Diagnostic Reagent 2009-2017 biochemical diagnoatics, immune dianostics, molecular diagnostics products market sales
Published Date: Sep 2013
Published By: QYResearch

Price: $2400
MediPoint: In-Vitro Colorectal Cancer Screening Tests - EU Analysis and Market Forecasts
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment.
Published Date: Aug 2013
Published By: GlobalData

Price: $4450
MediPoint: In-Vitro Colorectal Cancer Screening Tests - US Analysis and Market Forecasts
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment.
Published Date: Aug 2013
Published By: GlobalData

Price: $4450
MediPoint: In-Vitro Colorectal Cancer Screening Tests - APAC Analysis and Market Forecasts
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment.
Published Date: Aug 2013
Published By: GlobalData

Price: $4450
MediPoint: In-Vitro Colorectal Cancer Screening Tests - Current and Future Players
GlobalData has released its medical device report, MediPoint: In-Vitro Colorectal Cancer Screening Tests Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the steadily growing In-Vitro Colorectal Cancer Screening Tests Market. Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorecta
Published Date: Aug 2013
Published By: GlobalData

Price: $3500
MediPoint: In-Vitro Colorectal Cancer Screening Tests - South America Analysis and Market Forecasts
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment.
Published Date: Aug 2013
Published By: GlobalData

Price: $4450
Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
This report studies the global market for companion diagnostics from two perspectives – companion diagnostics by indication and by geography. The market for companion diagnostics by indication includes sub-segments such as breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma and others (HIV, Thalassemia). By geography, the companion diagnostics market has been divided into four regions, namely, North America, Europe, Asia-Pacific and RoW. Market size and forecast for each segment and sub-segment has been provided for the period 2011 to 2019 in terms of USD million, with 2012 as the base year. The compounded annual growth rate (CAGR) for each market segment has been provided for the forecast period (2013 to 2019). The report also contains a section on market ov
Published Date: Aug 2013
Published By: Transparency Market Research

Price: $4595
Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2012- 2016
TechNavio\'s analysts forecast the Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 16.37 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high prevalence of sleep apnea. The Global Sleep Apnea Diagnostic and Therapeutic Devices market has also been witnessing an increase in the adoption of home diagnostic devices. However, the lack of patient compliance could pose a challenge to the growth of this market. TechNavio\'s report, the Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2012- 2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas and the EMEA and APAC regions; it also covers the Global Sleep Apnea
Published Date: Aug 2013
Published By: Technavio

Price: $2000
MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment. Ques
Published Date: Aug 2013
Published By: GlobalData

Price: $6495
Research on China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2013-2017
Research on China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2013-2017” mainly conducts in-depth analysis on the external environment, market operation, import &export, as well as other aspects of China’s IVD reagent industry, and also summaries the latest development state in 2012 of key domestic enterprises, and finally forecasts the future industrial development. The information can provide investors with decision-making reference. IVD reagent industry is an emerging industry in China, the start is late and the development is relatively backward compares with occidental countries. According to the data provided by IVD Special Committee, there are 300 to 400 IVD reagent manufacturing enterprises in China, of which, 200 enterprises own above designated scale;
Published Date: Aug 2013
Published By: Huidian Research

Price: $1700
In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018
In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. This report estimates the market for the in vitro diagnostics terms of revenue (USD million) for the period 2012 – 2018, keeping 2011 as the base year. The in vitro diagnostics market is segmented into two major types namely market by geography and market by products. The market estimation for the U.S. and two emerging economies (China and India) have also been included in the report. The U.S., India and China in vitro diagnostics market is segmented by products into clinical chemistry IVDs, Immunoassay IVDs, diabetes testing IVDs, blood testing IVDs, molecular diagnostics, and other IVDs. The g
Published Date: Aug 2013
Published By: Transparency Market Research

Price: $4595
Research Report on Global and China In-vitro Diagnostic Reagent Industry, 2013-2017
In Chinese market, there are mainly three categories of invitro diagnostic reagents, biochemical diagnostic reagents, immune diagnostic reagents and molecular diagnostic reagents, accounting for about 65% of invitro diagnostic reagent market in total in 2012.  Global invitro diagnostics market is mature and the concentration rate is high. The 8 major enterprises account for over 70% market share. In 2011, the market scale of global invitro diagnostics reached USD 46 billion, among which developed countries accounted for over 80%. Currently, emerging economic entities occupy low proportions, while their growth rates are far ahead of that of mature markets.  In China, barriers to entry of this industry are not high and the concentration rate is low. The majority of enterprise
Published Date: Aug 2013
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $2200
Global In Vitro Diagnostics Market - Customization
Global In Vitro Diagnostics Market - Customization
Published Date: Jul 2013
Published By: Transparency Market Research

Price: $1750
Global IVD Products and Test Market-Strategic Volume and Pricing Analysis 2012-2016
TechNavio\'s analysts forecast the Global In Vitro Diagnostics (IVD) Products and Test market to grow at a CAGR of 4.33 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant growth of the IVD market in emerging countries. The market has also been witnessing a significant increase in the number of acquisitions of small and medium companies. However, the emergence of counterfeit or duplicate IVD products could pose a challenge to the growth of this market. TechNavio\'s report, the Global IVD Products and Test Market - Strategic Volume and Pricing Analysis 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions
Published Date: Jul 2013
Published By: Technavio

Price: $4000
Global Molecular Diagnostics Market Report: 2013 Edition
Human race has been persistently involved in a never ending pursuit for discovery and innovation in every field with a special inclination towards medical sciences. The perseverant efforts have triggered swift evolution in the realm of diagnostic tools and techniques. In-vitro diagnostic (IVD) tests are deployed for examining specimens including blood and tissues extracted from human body chiefly in order to detect the presence of concerning physiological/pathological state, or concerning congenital abnormality. Under the IVD market falls the ‘Molecular Diagnostics’ sector which involves performing analysis at the molecular level, and thereby measurement of DNA, RNA, proteins or metabolites to detect genotypes, mutations or biochemical changes, or to test for specific states
Published Date: Jul 2013
Published By: Koncept Analytics

Price: $800
Global Genetic Testing Market 2012-2016
TechNavio\'s analysts forecast the Global Genetic Testing market to grow at a CAGR of 9.45 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing global aging population. The Global Genetic Testing market has also been witnessing the increasing availability of Direct to Consumer (DTC) tests. However, the absence of credible standard procedures could pose a challenge to the growth of this market. TechNavio\'s report, the Global Genetic Testing Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Global Genetic Testing market landscape and its growth prospects in the coming years. Th
Published Date: Jul 2013
Published By: Technavio

Price: $2500
Avibactam - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Avibactam Avibactam indications: Treatment of Gram-negative bacterial infections including complicated intra-abdominal infections and complicated urinary tract infections in combination with Ceftazidime or Ceftaroline Avibactam innovator:  Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions
Published Date: Jun 2013
Published By: GenericsWeb

Price: $1200
Avibactam - Comprehensive patent search
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information. Pipeline Developer features:  Comprehensive patent searching, covering the world\'s key territories (see \'s
Published Date: Jun 2013
Published By: GenericsWeb

Price: $7200
Point of Care Diagnostics Market: Products, Players and Outlook
Vol 1: Cardiology Diagnostics | Vol 2: Hospital-based Diagnostics | Vol 3: Physician-based Diagnostics | Vol 4: Infectious Diseases Diagnostics A complete and practical analysis packed with facts, figures, forecasts and product/competitive assessments  Critical analysis and 5-year forecasts of key point-of-care diagnostic technologies, their prospects and the companies driving change and innovation. The In Vitro diagnostics market was worth approximately US$43 billion in 2011 and grew approximately 4% compared with 2010. The Point-of-Care (POC) sector represents 35% of the overall market and was valued at US$15.1 billion in 2011. The products covered in this report include those used by healthcare professionals and self-testers, which accounted for 33% of the POC sector,
Published Date: May 2013
Published By: Espicom

Price: $3615
Cell Culture Market (Media, Sera, Reagents, Serum-Free Media, Albumin, Growth Factors & Cytokines, Instruments, Bioreactors, Roller Bottle Equipment, T-Flasks And Cryostorage Equipment) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
The cell culture market is experiencing impressive growth globally because of the tremendous increase in demand for biopharmaceutical products. Since its introduction as an integral part of the life science industry, the cell culture market has experienced huge growth in terms of scope as well as adoption by end users. The rapid double-digit growth in biotechnology and biopharmaceutical industries is slated to be the major driving force for the growth of the cell culture market in the future. This report analyses the global market for cell culture by the two main types of products- consumables and instruments. Each of these segments has been further divided and analyzed by various product types offered by manufacturers. The market has also been segmented on the basis of end users in
Published Date: May 2013
Published By: Transparency Market Research

Price: $4595
In Vitro Diagnostics Markets in China
China's demand for in vitro diagnostics has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.
Published Date: May 2013
Published By: Asia Market Information & Development Company

Price: $2000
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Current and Future Players
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes Current and Future Players Summary Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency rooms every year with symptoms such as chest pain, and these patients are typically assessed with in vitro diagnostic cardiac biomarker tests. Emergence of two pipeline biomarker tests, Thermo Scientifics copeptin, and heart-type fatty acid binding protein (H-FABP), will provide further diagnostic options to emergency physicians.  Th
Published Date: Apr 2013
Published By: GlobalData

Price: $3500
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - EU Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes EU Analysis and Market Forecasts Summary In Europe, the ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and myoglobin. Furthermore, the emergence of pipeline biomarker tests will change the landscape of ACS in vitro diagnostic testing and is expected to provide enhancements in the early diagnosis of the disease. Acute coronary syndrome (ACS) consists of two major diseases, myocardial infarction (MI) and unstable angina,
Published Date: Apr 2013
Published By: GlobalData

Price: $4450
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - US Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes US Analysis and Market Forecasts Summary In the US, the ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and myoglobin. Furthermore, the emergence of pipeline biomarker tests will change the landscape of ACS in vitro diagnostic testing and is expected to provide enhancements in the early diagnosis of the disease. Acute coronary syndrome (ACS) consists of two major diseases, myocardial infarction (MI) and unstable ang
Published Date: Apr 2013
Published By: GlobalData

Price: $4450
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes APAC Analysis and Market Forecasts Summary The ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and myoglobin. Furthermore, the emergence of pipeline biomarker tests will change the landscape of ACS in vitro diagnostic testing and is expected to provide enhancements in the early diagnosis of the disease. Acute coronary syndrome (ACS) consists of two major diseases, myocardial infarction (MI) and unstable angina, with
Published Date: Apr 2013
Published By: GlobalData

Price: $4450
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - South America Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes South AmericaAnalysis and Market Forecasts Summary This report focuses on the Diagnostic Cardiac Biomarkers market in South America, principally Brazil. The ACS in vitro diagnostics market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and myoglobin. Furthermore, the emergence of pipeline biomarker tests will change the landscape of ACS in vitro diagnostic testing and is expected to provide enhancements in the early diagnosis of the disease. Also, due to the increasing number of cases of ACS in Brazil, GlobalData expects this ma
Published Date: Apr 2013
Published By: GlobalData

Price: $4450
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Global Analysis and Market Forecasts
Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency rooms every year with symptoms such as chest pain, and these patients are typically assessed with in vitro diagnostic cardiac biomarker tests. The ACS diagnostic cardiac biomarker reagents market is dominated by the cardiac troponins, the gold-standard biomarkers for the diagnosis of MI. In the US and Europe, the troponin market has reached saturation, therefore growth for these tests will be driven by increased uptake in the emerging markets of Braz
Published Date: Apr 2013
Published By: GlobalData

Price: $6495
Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis
Global Molecular Diagnostics Market & Future Forecast to 2017 Overview The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The next five years will witness significant developments in molecular diagnostics such as automation, as well as introduction of a wide range of new products. Molecular Diagnostics involves multiple technologies to identify genetic variations in individual patients. These technologies include PCR, FISH, hybrid capture, sequencing and microarrays. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a push from every side and many factors collectively are fuellin
Published Date: Apr 2013
Published By: Renub Research

Price: $1400
Global Plasma Market 2012-2016
TechNavio's analysts forecast the Global Plasma market to grow at a CAGR of 10.31 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Plasma market has also been witnessing the trend of increasing market consolidation. However, stringent regulations could pose a challenge to the growth of this market. TechNavio's report, the Global Plasma Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global plasma market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.Key vendor
Published Date: Mar 2013
Published By: Technavio

Price: $2000
Diagnostic Reagent Markets in China
China's demand for diagnostic reagent has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.
Published Date: Mar 2013
Published By: Asia Market Information & Development Company

Price: $2000
MediPoint: Predictive Breast Cancer Gene Testing - US Analysis and Market Forecasts
MediPoint: Predictive Breast Cancer Gene Testing US Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics position in the market is depe
Published Date: Feb 2013
Published By: GlobalData

Price: $4450
MediPoint: Predictive Breast Cancer Gene Testing - EU Analysis and Market Forecasts
MediPoint: Predictive Breast Cancer Gene Testing EU Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics position in the market is dependen
Published Date: Feb 2013
Published By: GlobalData

Price: $4450
MediPoint: Predictive Breast Cancer Gene Testing - APAC Analysis and Market Forecasts
MediPoint: Predictive Breast Cancer Gene Testing APAC Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics position in the market is de
Published Date: Feb 2013
Published By: GlobalData

Price: $4450
MediPoint: Predictive Breast Cancer Gene Testing - South America Analysis and Market Forecasts
MediPoint: Predictive Breast Cancer Gene Testing South America Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics position in the mar
Published Date: Feb 2013
Published By: GlobalData

Price: $4450
MediPoint: Predictive Breast Cancer Gene Testing - Current and Future Players
MediPoint: Predictive Breast Cancer Gene Testing Current and Future Players Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Improved surveillance in developing countries has allowed the identification of more women with breast cancer in these regions. Early diagnosis of breast cancer is essential for a good prognosis, making diagnosis a cornerstone of breast cancer control. Predictive gene testing can identify women who are at heightened risk of developing breast cancer due to hereditary gene factors. This report focuses on the predictive breast cancer gene testing markets in the US and
Published Date: Feb 2013
Published By: GlobalData

Price: $3500
China Thrombin Industry 2013 Market Research Report
2013 Market Research Report on China Thrombin Industry was professional and depth research report on China Thrombin industry.  The report firstly introduced Thrombin basic information included Thrombin definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Thrombin industry policy and plan, Thrombin product specification, manufacturing process, product cost structure etc. then statistics China key manufacturers Thrombin capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Thrombin products customers application capacity market posit
Published Date: Feb 2013
Published By: QYResearch

Price: $2000
MediPoint: Predictive Breast Cancer Gene Testing - Global Analysis and Market Forecasts
Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics position in the market is dependent on it being the leading provider of the most common breast cancer mutations. By the end of
Published Date: Feb 2013
Published By: GlobalData

Price: $6495
Point of Care Testing Market and Forecast to 2016: Global Analysis
Point of Care Testing Market Overview The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.  Blood glucose test controls a lion’s market share
Published Date: Jan 2013
Published By: Renub Research

Price: $1275
Indian In Vitro Diagnostics (IVD) Market: Trends & Opportunities (2012-2017)
Technological developments and rapid inventions in the field of medical sciences continue to provide the mankind with novel procedures, equipment, and practices. IVD is one of the latest technologies which are finding application in varied medical procedures globally. With its growing popularity and success rate, IVD has created a significant place in the worldwide medical diagnostics market. Focusing on the emerging economies of the world, especially Asian countries, like India, it has been noticed that areas like IVD are recording unabashed adoption in the medical fraternity, which is evident by its increasing market size. The present report offers an in-depth analysis of the global as well as the Indian IVD market, with a detailed discussion of its major segments: molecular diagn
Published Date: Dec 2012
Published By: Daedal Research

Price: $800
In vitro diagnostics market in Poland 2012
The IVD market in Poland has experienced growth due to technological advances and increased health awareness among Polish healthcare consumers. As a result, certain categories of tests have become routine procedures, and service providers, mainly large laboratory chains and testing centres, have expanded across the country and are likely to continue to do so in the coming years. In order to keep track of newly emerging segments and industry-leading businesses, suppliers and competitors active in this market find In vitro diagnostics market in Poland 2012, Development forecasts for 2012-2016, a publication prepared by the experts at PMR, to be an indispensible source of data and analysis when planning operations and sourcing new opportunities. This groundbreaking document examines
Published Date: Oct 2012
Published By: PMR

Price: $2660
In Vitro Toxicity Testing Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
This report covers global In vitro toxicity testing market along with their types and packaging. It also covers the performance of In vitro toxicity testing types and application in different regions of the world namely, North America, Europe, Asia and RoW (Rest of the World) along with their sub-segments. Moreover, the report provides in-depth analysis of In vitro toxicity testing types and application with their market estimated and forecast from 2011 to 2018, along with their compound annual growth rate from 2013 to 2018. The application of cosmetics and household industry, pharmaceutical industry, food industry and chemical industry has been covered in this report providing their market estimates and forecast from 2011 to 2018. Furthermore, the three main segments of In vitro to
Published Date: Oct 2012
Published By: Transparency Market Research

Price: $4595
Global In Vitro Diagnostics Market 2011-2015
TechNavio's analysts forecast the Global In Vitro Diagnostics market to grow at a CAGR of 6.55 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing demand for biomarker-based tests worldwide. The Global In Vitro Diagnostics market has also been witnessing increased adoption of DNA probe-based diagnostics. However, challenges in the POC segment could pose a challenge to the growth of this market.TechNavio's research report, the Global In Vitro Diagnostics Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global In Vitro Diagnostics market landscape and its growth prospects in the coming years.
Published Date: Sep 2012
Published By: Technavio

Price: $2000
In Vitro Diagnostics Market in India 2012
The in vitro diagnostics market in India has gathered momentum in the last few years. Several companies, both domestic as well as foreign are entering the business with enthusiasm due to the tremendous growth the industry has been experiencing. The steadily growing number of medical centers in the country along with the ever increasing patient population will result in a growing target base of consumers which in turn will result the market to exhibit steady growth in future. The report begins with the introduction section which offers a brief insight to the concept of in vitro diagnostic equipments, along with a broad segmentation of the in vitro diagnostic equipments. The value chain of IVD has also been provided in this section which gives the progressive stages of manufacturing o
Published Date: Sep 2012
Published By: Netscribes (India) Pvt. Ltd.

Price: $795
Research Report on China`s In-vitro Diagnostic Reagent Industry, 2012
In-vitro diagnostics is a diagnostics method through detecting samples (blood, body fluid, tissues, etc.) taken out from human bodies so as to judge diseases and functions of organisms. In most cases, the detection system composed of detection instruments and reagents are applied in in-vitro diagnostics. In-vitro diagnostic reagents are used to carry out in-vitro detection for human samples. In Chinese market, there are mainly three categories, biochemical diagnostic reagents, immune diagnostic reagents and molecule diagnostic reagents, accounting for over 60% of the market share of in-vitro diagnostic reagents in total in 2011.  The global in-vitro diagnostics market is mature and the concentration rate is high. Major 8 enterprises account for over 70% of the market share.
Published Date: Jun 2012
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $3000
Assessment of the Asia-Pacific In-Vitro Diagnostic (IVD) Market
The In-Vitro Diagnostics (IVD) industry endured the impact of the global recession, with key players introducing more efficient and effective devices. The growth in the Asian region is driving the growth of the global IVD market. Within Asia, the IVD market is dominated by China and India, where factors such as rising awareness, increased patient self testing and economic affluence are supporting the growth of the IVD sector. The prevalence of chronic and infectious diseases in the region has led to the increased focus of the governments on improving the healthcare facilities. The segments expected to witness high growth in the Asia IVD market are molecular diagnostics, point-of-care tests and self-monitoring blood glucose. However, the industry is struggling with challenges such
Published Date: Feb 2012
Published By: Smart Research Insights

Price: $800
Global In Vitro Diagnostics (IVD) Market Report: 2011 Edition
In-vitro diagnostics (IVD), which includes testing from assays in a controlled environment outside the living organism, accounts for a major share in the global diagnostics market. Despite the global economic crisis, the market registered growth mainly on the back of introduction of novel technologies, rapidly ageing population, increasing health awareness, and increasing contribution of the emerging countries.On the basis of technology, Immunochemistry dominates the global IVD market, followed by Diabetes Care. North America represents the largest IVD market worldwide, followed by Europe and Japan. In the coming years, these mature markets would offer less potential for growth, whereas the emerging markets like Asia Pacific and Latin America would offer immense potential for growth.Point
Published Date: Oct 2011
Published By: Koncept Analytics

Price: $800